Pharmaceutical preparations
CA 2061370 A1 · Owner: Tschopp, Thomas B. · Inventors: Hosang, Markus; Iberg, Niggi; Wessel, Hans Peter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract, The use of compounds of the formula wherein R is hydrogen or a residue -SO3M; M is a cation; and R' and R" are hydrogen or an .alpha.-glycosidically linked sulphated mono- or disaccharide residue; and at least one -SO3M group is present per monosaccharide unit, for the manufacture of pharmaceutical preparations for the prevention and/or treatment of arteriosclerotic disorders and for the prevention of restenoisis after invasive vascular surgery and after organ transplants.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 17, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 17, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 17, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.